These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38986098)

  • 1. [Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure].
    Barthou A; Kamel R; Leroy J; Vandecasteele G; Fischmeister R
    Med Sci (Paris); 2024; 40(6-7):534-543. PubMed ID: 38986098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic nucleotide phosphodiesterases as therapeutic targets in cardiac hypertrophy and heart failure.
    Kamel R; Leroy J; Vandecasteele G; Fischmeister R
    Nat Rev Cardiol; 2023 Feb; 20(2):90-108. PubMed ID: 36050457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases.
    Kokkonen K; Kass DA
    Annu Rev Pharmacol Toxicol; 2017 Jan; 57():455-479. PubMed ID: 27732797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure.
    Stehlik J; Movsesian MA
    Expert Opin Investig Drugs; 2006 Jul; 15(7):733-42. PubMed ID: 16787138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyclic nucleotide phosphodiesterases: role in the heart and therapeutic perspectives].
    Bedioune I; Bobin P; Karam S; Lindner M; Mika D; Lechêne P; Leroy J; Fischmeister R; Vandecasteele G
    Biol Aujourdhui; 2016; 210(3):127-138. PubMed ID: 27813474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes.
    Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R
    Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.
    Wen JF; Cui X; Jin JY; Kim SM; Kim SZ; Kim SH; Lee HS; Cho KW
    Circ Res; 2004 Apr; 94(7):936-43. PubMed ID: 14988225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in phosphodiesterase activity in the developing rat submandibular gland.
    Tanaka S; Shimooka S; Shimomura H
    Arch Oral Biol; 2002 Aug; 47(8):567-76. PubMed ID: 12221013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Cyclic Nucleotide Phosphodiesterases: Roles and Therapeutic Potential in Heart Failure.
    Preedy MEJ
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):401-417. PubMed ID: 32172427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rabbit corpus cavernosum smooth muscle shows a different phosphodiesterase profile than human corpus cavernosum.
    Qiu Y; Kraft P; Lombardi E; Clancy J
    J Urol; 2000 Sep; 164(3 Pt 1):882-6. PubMed ID: 10953172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review.
    Yasmeen S; Akram BH; Hainsworth AH; Kruuse C
    Cell Signal; 2019 Sep; 61():108-119. PubMed ID: 31132399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.
    Zhang L; Bouadjel K; Manoury B; Vandecasteele G; Fischmeister R; Leblais V
    Br J Pharmacol; 2019 Jun; 176(11):1780-1792. PubMed ID: 30825186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of cyclic nucleotide phosphodiesterase isoforms in cAMP compartmentation following beta2-adrenergic stimulation of ICa,L in frog ventricular myocytes.
    Jurevicius J; Skeberdis VA; Fischmeister R
    J Physiol; 2003 Aug; 551(Pt 1):239-52. PubMed ID: 12815180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of cAMP and cGMP phosphodiesterases in isolated ventricular cardiomyocytes from human hearts: comparison with rat and guinea pig.
    Johnson WB; Katugampola S; Able S; Napier C; Harding SE
    Life Sci; 2012 Feb; 90(9-10):328-36. PubMed ID: 22261303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.
    Ahmad F; Murata T; Shimizu K; Degerman E; Maurice D; Manganiello V
    Oral Dis; 2015 Jan; 21(1):e25-50. PubMed ID: 25056711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic nucleotide phosphodiesterases in heart and vessels: A therapeutic perspective.
    Bobin P; Belacel-Ouari M; Bedioune I; Zhang L; Leroy J; Leblais V; Fischmeister R; Vandecasteele G
    Arch Cardiovasc Dis; 2016; 109(6-7):431-43. PubMed ID: 27184830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.